-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Quest Diagnostics, Raises Price Target to $190

Benzinga·05/06/2025 11:50:25
Listen to the news
JP Morgan analyst Lisa Gill maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $180 to $190.